STATESVILLE, N.C., June 26 /PRNewswire-FirstCall/ -- Kewaunee
Scientific Corporation (NASDAQ:KEQU) today reported results for its
fiscal year and fourth quarter ended April 30, 2007. Net earnings
for the year were $1,540,000, or $0.62 per diluted share, as
compared to net earnings of $193,000, or $0.08 per diluted share,
for the prior year. Excluding an after-tax gain of $540,000 in the
prior year related to the sale of the Company's former Lockhart,
Texas property, a net loss of $347,000, or $0.14 per diluted share,
was incurred for that year. Earnings for the current year benefited
from significantly improved manufacturing costs, continuing success
in identifying new global supply sources for raw materials and
components, and other cost improvement initiatives. Sales for the
year were $81,441,000, a decrease of 3.1% from sales of $84,071,000
in the prior year. Incoming orders, both domestic and
international, were extremely strong in the second half of the year
and included several prestigious laboratory furniture projects. The
order backlog climbed to $51.1 million at April 30, 2007, an
increase of $14.7 million from $36.4 million at April 30, 2006.
Sales from domestic operations were $66,585,000, a decrease of 7.6%
from the prior year. However, as reflected in the growth of the
Company's order backlog, the domestic marketplace for laboratory
products continues to be healthy, particularly for larger
laboratory projects. The Company's international operations
continued to experience strong sales, as sales increased 23.3% to
$14,856,000. The Asian markets of India, Singapore, and China
continue to be a key in the Company's long-term growth strategy.
During the year, the Company strengthened its sales representation
in these countries and further expanded its manufacturing
capabilities in India. Confirming the Company's excellent
reputation in the Asian laboratory furniture market, during the
year the Company was awarded a prestigious contract to provide and
install laboratory furniture and fume hoods for the Olympic testing
laboratory in Beijing, China. This laboratory will test all
athletes who participate in the 2008 Summer Olympics in Beijing and
will be one of only a few laboratories in the world designed to
comply with the stringent standards required for a laboratory to be
certified by the International Olympics Committee. The order will
be shipped and installed in the first quarter of fiscal year 2008.
"We ended fiscal year 2007 with very positive momentum," said
William A. Shumaker, President and Chief Executive Officer. "The
strong influx of orders in the last half of the year provides us a
foundation for increased sales in fiscal year 2008 when the
majority of these orders will be shipped. Our lower costs are
making us more competitive in the domestic marketplace, while also
improving our profit margins and profitability. Our international
operations continue to grow in sales and profitability. Excellent
progress was also made during the year in improving our financial
position, as we significantly improved cash flow, reduced
borrowings, and strengthened our balance sheet. These factors
should place the Company on a solid track for continued success and
profitability." During the year, the Company generated cash from
operations of $8.7 million. Bank borrowings and capital lease
obligations totaled $4.3 million at year-end, down from $9.1
million at the end of the prior year. The debt-to- equity ratio
declined to .18-to-1 at year-end, and cash on hand increased to
$2.6 million, up from $1.3 million at the end of the prior year.
Working capital was $12.3 million at April 30, 2007, up from $11.0
million at the end of the prior year. Sales for the fourth quarter
ended April 30, 2007 were $22,721,000, a decrease of 4.2% from
sales of $23,720,000 in the same quarter of the prior year. Sales
from domestic operations for the quarter were flat from the same
quarter of the prior year, while sales from international
operations declined because especially large shipments were made
for several projects in the fourth quarter of the prior year. Net
earnings for the fourth quarter were $517,000, or $.21 per diluted
share, as compared to a net loss of $254,000, or $0.11 per diluted
share, in the prior year. Kewaunee Scientific Corporation is a
recognized leader in the design, manufacture, and installation of
scientific and technical furniture. The Company's corporate
headquarters and domestic manufacturing facilities are located in
Statesville, North Carolina. The Company also has subsidiaries in
Singapore and Bangalore, India that serve the Asian markets.
Kewaunee Scientific's website is located at
http://www.kewaunee.com/. Certain statements in this release
constitute "forward-looking" statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that could significantly impact
results or achievements expressed or implied by such
forward-looking statements. These factors include, but are not
limited to, economic, competitive, governmental, and technological
factors affecting the Company's operations, markets, products,
services, and prices. Contact: D. Michael Parker 704/871-3290
Consolidated Statements of Operations (in thousands, except per
share amounts) Three Months Ended Year Ended April 30 April 30 2007
2006 2007 2006 (Unaudited) Net sales $22,721 $23,720 $81,441
$84,071 Cost of products sold 18,467 20,629 66,355 71,663 Gross
profit 4,254 3,091 15,086 12,408 Other operating income -- -- --
884* Operating expenses 3,363 3,223 11,728 12,175 Operating
earnings (loss) 891 (132) 3,358 1,117 Other income 20 51 53 50
Interest expense (146) (153) (670) (470) Earnings (loss) before
income taxes 765 (234) 2,741 697 Income tax expense (benefit) 289
(38) 902 288 Earnings (loss) before minority interests 476 (196)
1,839 409 Minority interests in subsidiaries 41 (58) (299) (216)
Net earnings (loss) $517 $(254) $1,540 $193* Net earnings (loss)
per share Basic $0.21 $(0.11) $0.62 $0.08 Diluted $0.21 $(0.11)
$0.62 $0.08 Weighted average number of common shares outstanding
(in thousands) Basic 2,494 2,492 2,493 2,492 Diluted 2,502 2,492
2,495 2,493 * Includes a non-recurring pretax gain of $884,000 and
an after-tax gain of $540,000, or $.22 per diluted share, on the
sale of property. Condensed Consolidated Balance Sheets (in
thousands) April 30 April 30 Assets 2007 2006 Cash and cash
equivalents $2,231 $929 Restricted cash 372 399 Receivables, less
allowances 19,061 23,199 Inventories 5,869 5,860 Prepaid expenses
and other current assets 981 1,011 Total current assets 28,514
31,398 Net property, plant and equipment 11,255 11,163 Other assets
5,471 7,911 Total Assets $45,240 $50,472 Liabilities and
Stockholders' Equity Short-term borrowings $3,489 $8,216 Current
obligations under capital leases 360 260 Accounts payable 8,437
9,074 Other current liabilities 3,897 2,823 Total current
liabilities 16,183 20,373 Other non-current liabilities 5,009 4,553
Total stockholders' equity 24,048 25,546 Total Liabilities and
Stockholders' Equity $45,240 $50,472 DATASOURCE: Kewaunee
Scientific Corporation CONTACT: D. Michael Parker, Kewaunee
Scientific Corporation, +1-704-871-3290 Web site:
http://www.kewaunee.com/
Copyright
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
Von Jul 2023 bis Jul 2024